This five-year study proposes to examine and evaluate the process of treatment service delivery with a special focus on the roles and functions of drug treatment counselors. The study will have two related but distinctive components. The first component is a survey of all counselors in 40 treatment programs selected in Los Angeles County and a record abstraction of these counselors' clients who entered the program within the past 12 months. The 40 treatment programs will include five modalities (e.g., outpatient drug free programs, residential or therapeutic community programs, methadone maintenance outpatient programs, hospital inpatient programs, and day treatment programs) for which program level information (e.g., policy, philosophy, staffing, service provision, etc.) are currently being collected in a treatment survey conducted by the PI. Together with interviews of program directors and treatment survey data, these data (e.g., counselor survey and client record abstraction will provide comprehensive information at program, counselor, and client levels. A set of multilevel analyses (e.g., Hierarchical Linear Models) will be applied to these hierarchical data to assess client outcome (e.g., treatment retention) as functions of multilevel influences including program, counselor, and client variation. The second component of the study is a prospective, longitudinal substudy which includes a smaller set of counselors and their clients for in-depth face-to-face interviews. Clients will be interviewed again six months after the initial contact. This substudy is designed to obtain detailed measures on the counselor-client therapeutic relationship and on relevant multiple outcomes. The selection criteria of counselors will be determined by the results from the first component of the study (e.g., the counselor survey and retrospective counselor evaluation). Particular attention will be paid to dimensions that suggest effective practices or approaches that can be incorporated into counselor training programs. A computerized system will be developed to establish the database and to provide timely data analysis. Extensive statistical analyses and model applications will be performed. The study will enhance knowledge about the current roles and functions of drug treatment counselors in the treatment system, identify determinants of effective counselors, and contribute to improved client outcomes by identifying counselor characteristics that will be useful in matching clients to appropriate treatment. The multilevel data collection and analysis should lead to important breakthroughs in the study of client outcomes in relation to program, counselor, and client characteristics.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008757-02
Application #
2121479
Study Section
Special Emphasis Panel (SRCD (44))
Project Start
1993-09-30
Project End
1998-08-31
Budget Start
1994-09-01
Budget End
1995-08-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Rand Corporation
Department
Type
DUNS #
City
Santa Monica
State
CA
Country
United States
Zip Code
90401
Hser, Yih-Ing; Huang, David; Teruya, Cheryl et al. (2003) Gender comparisons of drug abuse treatment outcomes and predictors. Drug Alcohol Depend 72:255-64
Kasarabada, Nagalakshmi D; Hser, Yih-Ing; Boles, Sharon M et al. (2002) Do patients' perceptions of their counselors influence outcomes of drug treatment? J Subst Abuse Treat 23:327-34
Marshall, Grant N; Hser, Yih-Ing (2002) Characteristics of criminal justice and noncriminal justice clients receiving treatment for substance abuse. Addict Behav 27:179-92
Kasarabada, N D; Hser, Y I; Parker, L et al. (2001) A self-administered instrument for assessing therapeutic approaches of drug-user treatment counselors. Subst Use Misuse 36:273-99
Grella, C E; Polinsky, M L; Hser, Y I et al. (1999) Characteristics of women-only and mixed-gender drug abuse treatment programs. J Subst Abuse Treat 17:37-44
Grella, C E; Hser, Y I (1997) A county survey of mental health services in drug treatment programs. Psychiatr Serv 48:950-2